Contents of this document
- Total investment income2025Q1-¥755 million2026Q1¥275 millionYear on year against the same period last year+¥1 billion
- Recurring revenue2025Q1¥1.7 billion2026Q1¥2 billionYear on year against the same period last year+¥0.3 billion
- Realized carried interest2025Q1¥02026Q1¥8.9 billionYear on year against the same period last year+¥8.9 billion
- Capital investment in 八十島プロシード株式会社
- 3 additional investments in existing veterinary hospital groups
- Final close of Real Estate Fund No. 1
- Establishment of a JV and co-investment fund with Granite Asia Capital
- Execution of 2 global technology growth investments
- FE-AUM3,685 Hundreds of millions of yen
- AUM5,103 Hundreds of millions of yen
- Fund fair value3,156 Hundreds of millions of yen
- Economic net asset value855 Hundreds of millions of yen
- Unrealized carried interest552 Hundreds of millions of yen
- No. 3 series DPI3.2 times
- No. 4 series DPI0.8 times
- Gross MOIC3.1 times
- Gross IRR30.5 %
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | First quarter of the fiscal year ending December 2026 |
| Net Sales | ¥11,283 million |
| Operating profit | ¥9,680 million |
| Ordinary income | ¥9,659 million |
| Net income | ¥6,732 million |
| Selling, general and administrative expenses | ¥1,602 million |
| Results for the three months of the current quarter | Revenue ¥11,283 million / Operating profit ¥9,680 million / Profit before tax ¥9,659 million / Profit for the period ¥6,732 million |
| Segment results | Private equity investment business Revenue ¥10,535 million / Segment profit ¥9,648 million / Real Estate Investment Business Revenue ¥683 million / Segment profit ¥575 million / Other Revenue ¥64 million / Segment profit ¥16 million |
| Breakdown of Factors Affecting the Change | Factors Total investment income / 2025Q1 -¥755 million / 2026Q1 ¥275 million / Year on year against the same period last year +¥1 billion, Factors Recurring revenue / 2025Q1 ¥1.7 billion / 2026Q1 ¥2 billion / Year on year against the same period last year +¥0.3 billion, Factors Realized carried interest / 2025Q1 ¥0 / 2026Q1 ¥8.9 billion / Year on year against the same period last year +¥8.9 billion |
| Key KPIs | Indicator FE-AUM / Value 3,685 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator AUM / Value 5,103 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator Fund fair value / Value 3,156 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator Economic net asset value / Value 855 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator Unrealized carried interest / Value 552 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator No. 3 series DPI / Value 3.2 times / Year on year against the same period last year Not disclosed, Indicator No. 4 series DPI / Value 0.8 times / Year on year against the same period last year Not disclosed, Indicator Gross MOIC / Value 3.1 times / Year on year against the same period last year Not disclosed, Indicator Gross IRR / Value 30.5 % / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees 74 investment professionals / 115 employees group-wide / Change during the period Not disclosed |
| Financial targets | Five-year average ROE Approximately 15% / DOE 2% / Principal investment return MOIC Approximately 3.0x |
| Payout ratio | DOE 2% |
| New initiatives | Capital investment in 八十島プロシード株式会社, 3 additional investments in existing veterinary hospital groups, Final close of Real Estate Fund No. 1, Establishment of a JV and co-investment fund with Granite Asia Capital, Execution of 2 global technology growth investments |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.¥8.9 billion in carried interest income was received from the No. 3 fund series, while recurring revenue increased following the start of the investment period for the No. 5 fund series. In real estate, investment income increased due to the reflection of transaction prices for assets sold and changes in valuation methods, among other factors. In PE, fair value declined due to share-price fluctuations at listed portfolio companies and deterioration in various indicators at unlisted portfolio companies.